AI-generated summary
The authors studied 32 adult male mice in which busulfan was used to induce azoospermia, then treated them with photobiomodulation at two energy densities. They report that the 0.03 J/cm2 treatment was associated with higher testosterone, more spermatogenic cells, fewer apoptotic cells and improved oxidative markers compared with busulfan-only mice. The study is in mice and the abstract suggests a possible but unconfirmed benefit for human patients.
- Participants
- 32
- Who or what was studied
- Adult NMRI male mice with busulfan-induced testicular degeneration and azoospermia
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report human data or the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 0.03 J/cm2, 0.2 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species, Adenosine triphosphate, Laser, Dose, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.